IDBS to Host London Translational & Biomarker Research Symposium 2011

Industry Experts Share Best Practices in Translational Medicine to Advance Healthcare

Guildford, UK, and Burlington, Mass., October 11, 2011 - IDBS, a global provider of innovative data management, analytics and modeling solutions, today announced it will host its 3rd annual Translational & Biomarker Research Symposium (TRS) on Wednesday October 19, 2011 in London.

The healthcare field is moving towards a new era in personalised medicine. This exciting development brings with it many challenges, namely how to integrate the rapidly growing availability of clinical, molecular and other research information. IDBS is shaping the future of personalised medicine by working with many UK hospitals, such as King’s Health Partners, as well as the Technology Strategy Board, to provide a platform to  bring genetic information into a clinical environment and ultimately improve disease understanding and patient outcomes.

The London Symposium reflects the UK’s increasing presence as a centre for these pioneering developments in healthcare. Presenters will discuss the drive towards personalised medicine including:

• Addressing data challenges around the explosion in Next Generation Sequencing data, access to clinical data and bottlenecks in accessing bioinformatic and statistical analytics
• Supporting secure translational medicine collaboration between academic medical centres, pharmaceutical and diagnostics organisations

The symposium features international experts who will share their best practices in this new frontier for healthcare.

Speakers include:

• Professor Alan Ashworth, Chief Executive, The Institute of Cancer Research
• Professor Peter Parker, Deputy Director of the Integrated Cancer Centre, Head of the Division of Cancer  Studies at King's College London and Co-Director of the King's College London Experimental Cancer Medicine Centre
• Emanuele de Rinaldis, Ph.D., Bioinformatics Team Leader, Breakthrough Breast Cancer Research Unit - Division of Cancer Studies at King's College London
• Lars Engstrom, Project Lead / Solutions Architect at Guy's & St Thomas' Foundation Trust
• James Cai, Ph.D., Head, Disease & Translational Informatics, Pharma Research & Early Development (pRED) Informatics, Hoffmann-La Roche
• Dominick Sinicropi, Ph.D., Staff Scientist, Genomic Health
• James Peach, Director of Stratified Medicine, Cancer Research UK
• Paul Denny-Gouldson, Ph.D., VP Translational Medicine, IDBS
• Dr. Jason Blue-Smith, Product Manager Informatics, Illumina Hayward
• Dr. David de Graaf, President and Chief Executive Officer, Selventa

"We’re delighted that such a distinguished group of experts in the translational medicine field are speaking at TRS this year,” said Neil Kipling, founder and CEO of IDBS. “We’re very much looking forward to hearing their experiences and expertise at this event. The high caliber of speakers is a reflection of IDBS’ first class solutions in healthcare informatics, which are rapidly being adopted by global healthcare centres, as well as our dedication to the advancement of personalised medicine.”

The IDBS Translational & Biomarker Research Symposium will be held at Millbank Tower, London.

About IDBS

IDBS is a global provider of innovative enterprise data management, analytics and modeling solutions. The company’s uniquely sophisticated platform technologies are used by more than 200 pharmaceutical companies, major healthcare providers, global leaders in academic study, and high tech companies to increase efficiency, reduce costs and improve the productivity of industrial R&D and clinical research. IDBS is clearly differentiated by its unique combination of award-winning enterprise technologies and domain knowledge in R&D.

IDBS’ solutions help scientists, hospitals and R&D businesses produce the world’s newest therapeutics, diagnostics and personalized treatments, high-tech materials and consumer products, faster, cleaner engines and fuels, breakthroughs in productive agriculture, healthy, safer food products, and high tech materials and products.

Founded in 1989 and privately held, IDBS is headquartered in Guildford, UK with a direct sales and support presence worldwide. IDBS is a 2010 Profit Track 100 company and the recipient of multiple awards including the Frost and Sullivan 'Enabling Technology' Award in R&D data management for 2010 and Queen's Award for International Trade 2011. For regular updates follow us on Twitter @IDBSsoftware

For media enquiries, please contact:

Danielle Guinebertiere, IDBS Communications Director
Tel: +1 908 429 2933
Email: dguinebertiere@idbs.com